Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells

Journal of Nutrition

Volumn 141, Issue 6, 2011, Pages 1041-1048

  Rockett, Benjamin Drew ^a   Franklin, Andrew ^a   Harris, Mitchel ^a   Teague, Heather ^a   Rockett, Alexis ^a   Shaikh, Saame Raza ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; DIET; EX VIVO STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IN VITRO STUDY; LIPID RAFT; MALE; MOUSE; NONHUMAN;

ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELL SIZE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FLUORESCENCE RESONANCE ENERGY TRANSFER; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL;

MUS;

EID: 79958183696     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.138750     Document Type: Article

References (50)

1. Fetterman JW Jr, Zdanowicz MM. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm. 2009; 66:1169-79.
2. Moghadasian MH. Advances in dietary enrichment with n-3 fatty acids. Crit Rev Food Sci Nutr. 2008;48:402-10.
3. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002; 106:2747-57.
4. Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care. 2009;12:138-46.
5. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, Quignard-Boulange A, Vidal H, Slama G, et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized ontrolled study. Am J Clin Nutr. 2007;86:1670-9.
6. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007;29:1354-7.
7. Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem Phys Lipids. 2008;153:14-23.
8. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2007;77:327-35.
9. Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab. 2009;55: 123-39.
10. Yaqoob P, Shaikh SR. The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care. 2010;13:156-66.
11. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46-50.
12. Shaikh SR, Rockett BD, Salameh M, Carraway K. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells. J Nutr. 2009;139:1632-9.
13. Shaikh SR, Edidin MA. Membranes are not just rafts. Chem Phys Lipids. 2006;144:1-3.
14. Wassall SR, Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids. 2008;153:57-63.
15. Shaikh SR, Cherezov V, Caffrey M, Soni SP, LoCascio D, Stillwell W, Wassall SR. Molecular organization of cholesterol in unsaturated phosphatidylethanolamines: X-ray diffraction and solid state 2H NMR reveal differences with phosphatidylcholines. J Am Chem Soc. 2006;128:5375-83.
16. Shaikh SR, LoCascio DS, Soni SP, Wassall SR, Stillwell W. Oleic- and docosahexaenoic acid-containing phosphatidylethanolamines differentially phase separate from sphingomyelin. Biochim Biophys Acta. 2009; 1788:2421-6.
17. Schley PD, Brindley DN, Field CJ. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast ancer cells. J Nutr. 2007;137:548-53.
18. Fan YY, McMurray DN, Ly LH, Chapkin RS. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr. 2003;133:1913-20.
19. Li Q, Tan L, Wang C, Li N, Li Y, Xu G, Li J. Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts. Eur J Nutr. 2006;45:144-51.
20. Lichtenberg D, Goñi FM, Heerklotz H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci. 2005;30:430-6.
21. Heerklotz H. Triton promotes domain formation in lipid raft mixtures. Biophys J. 2002;83:2693-701.
22. Lingwood D, Simons K. Detergent resistance as a tool in membrane research. Nat Protoc. 2007;2:2159-65.
23. Rockett BD, Salameh M, Carraway K, Morrison K, Shaikh SR. N-3 PUFA improve fatty acid composition, prevent palmitate-induced apoptosis, and differentially modify B cell cytokine secretion in vitro and ex vivo. J Lipid Res. 2010;51:1284-97.
24. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127:S838-41.
25. Shaikh SR, Edidin M. Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules. J Lipid Res. 2007;48:127-38.
26. Gomez-Mouton C, Lacalle RA, Mira E, Jimenez-Baranda S, Barber DF, Carrera AC, Martinez-A. C, Manes S. Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J Cell Biol. 2004;164:759-68.
27. Seveau S, Eddy RJ, Maxfield FR, Pierini LM. Cytoskeleton-dependent membrane domain segregation during neutrophil polarization. Mol Biol Cell. 2001;12:3550-62.
28. Bowness P, Caplan S, Edidin M. MHC molecules lead many lives. workshop on MHC class I molecules at the interface between biology & medicine. EMBO Rep. 2009;10:30-4.
29. Edidin M. Class I MHC molecules as probes of membrane patchiness: from biophysical measurements to modulation of immune responses. Immunol Res. 2010;47:265-72.
30. Goebel J, Forrest K, Flynn D, Rao R, Roszman TL. Lipid rafts, major histocompatibility complex molecules, and immune regulation. Hum Immunol. 2002;63:813-20.
31. Kenworthy AK, Petranova N, Edidin M. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell. 2000;11:1645-55.
32. Kenworthy AK, Edidin M. Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of,100 A using imaging fluorescence resonance energy transfer. J Cell Biol. 1998;142:69-84.
33. Wu P, Brand L. Resonance energy transfer: methods and applications. Anal Biochem. 1994;218:1-13.
34. Bastiaens PI, Jovin TM. Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C eta I. Proc Natl Acad Sci USA. 1996;93:8407-12.
35. Image J. Available from: http://rsbweb.nih.gov/ij/.
36. Stepensky D. FRETcalc plugin for calculation of FRET in noncontinuous intracellular compartments. Biochem Biophys Res Commun. 2007;359:752-8.
37. Thumser AE, Storch J. Characterization of a BODIPY-labeled fluorescent fatty acid analogue. binding to fatty acid-binding proteins, intracellular localization, and metabolism. Mol Cell Biochem. 2007;299:67-73.
38. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126:1-27.
39. Verlengia R, Gorjao R, Kanunfre CC, Bordin S, de Lima TM,Martins EF, Newsholme P, Curi R. Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells. Lipids. 2004;39:857-64.
40. Mannini A, Kerstin N, Calorini L, Mugnai G, Ruggieri S. Dietary n-3 polyunsaturated fatty acids enhance metastatic dissemination of murine T lymphoma ells. Br J Nutr. 2009;102:958-61.
41. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods. 2000;243:147-54.
42. + T cells by affecting lipid raft formation. J Immunol. 2008;181:6236-43.
43. Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, Harder T. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR ignaling. EMBO J. 2009;28:466-76.
44. Rogers KR, Kikawa KD, Mouradian M, Hernandez K, McKinnon KM, Ahwah SM, Pardini RS. Docosahexaenoic acid alters epidermal growth factor receptor related signaling by disrupting its lipid raft association. Carcinogenesis. 2010;31:1523-30.
45. ChenW, Jump DB, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2007;48:18-26.
46. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny P, Waldhausl W. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem. 2001;276:37335-40.
47. Chapkin RS, Wang N, Fan Y, Lupton JR, Prior IA. Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys cta. 2008;1778:466-71.
48. Shi J, Yang T, Kataoka S, Zhang Y, Diaz AJ, Cremer PS. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. J Am Chem oc. 2007;129:5954-61.
49. Wong SW, Kwon M, Choi AMK, Kim H, Nakahira K, Hwang DH. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem. 2009;284:27384-92.
50. Altenburg JD, Siddiqui RA. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. ol Cancer Res. 2009;7:1013-20.